Within 24 hours of last week, an expert committee from the national drug regulator changed its decision on whether Bharat Biotech’s Covid-19 candidate vaccine could be recommended for approval without evidence of its efficacy in humans, the minutes of the committee meetings held on January 1 and 2 show. The …
Read More »Oxford COVID-19 Covishield Vaccine, Bharat Biotech’s Covaxin Gain DCGI Approval for Emergency Use
The indigenous vaccine developed by Bharat Biotech with the Indian Council for Medical Research (ICMR) will be used as a ‘backup’, only if the country needs additional doses to vaccinate large numbers of people, particularly given the possibility of an increase sudden triggered by the UK variant. And, unlike the …
Read More »Oxford COVID-19 Covishield Vaccine, Bharat Biotech’s Covaxin Gain DCGI Approval for Emergency Use
The indigenous vaccine developed by Bharat Biotech with the Indian Council for Medical Research (ICMR) will be used as a ‘backup’, only if the country needs additional doses to vaccinate large numbers of people, particularly given the possibility of an increase sudden triggered by the UK variant. And, unlike the …
Read More »One day after Oxford, the expert panel approves the indigenous Bharat Biotech vaccine
An expert panel from India’s top drug regulator on Saturday recommended restricted emergency approval for Covaxin, Bharat Biotech’s Covid-19 candidate vaccine currently being tested in the country. The panel of experts now recommended a restricted authorization for two candidate vaccines in as many days; on Friday, it recommended similar approval …
Read More »Expert Panel Recommends Granting Approval for Emergency Restricted Use of Covaxin from Bharat Biotech
An expert panel from India’s central drug authority on Saturday recommended granting permission for the restricted use of the indigenous COVID-19 vaccine developed by Bharat Biotech Covaxin in an emergency situation, especially in the context of infection by mutant strains, authorities said. The recommendation for the Bharat Biotech vaccine came …
Read More »Covaxin Animal Trial Elicits Strong Immune Responses: Bharat Biotech | India News
NEW DELHI: Bharat Biotech International Limited has announced that its Covid-19 vaccine candidate, Covaxin, has shown positive efficacy in animal studies and has generated strong immune responses. Covaxin, developed by the Indian Council for Medical Research and Bharat Biotech, is being tested in 12 institutes in India. This indigenous vaccine …
Read More »